Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP680444.RAx3uUdxrtpiivpJjYfegh2wiIEaBt6C8UFgdzBhFxTjc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP680444.RAx3uUdxrtpiivpJjYfegh2wiIEaBt6C8UFgdzBhFxTjc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP680444.RAx3uUdxrtpiivpJjYfegh2wiIEaBt6C8UFgdzBhFxTjc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP680444.RAx3uUdxrtpiivpJjYfegh2wiIEaBt6C8UFgdzBhFxTjc130_provenance.
- NP680444.RAx3uUdxrtpiivpJjYfegh2wiIEaBt6C8UFgdzBhFxTjc130_assertion description "[These novel findings, together with the previously known immune-activating features of CD40L, support the potential applicability of AdEHCD40L for experimental treatment of human breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP680444.RAx3uUdxrtpiivpJjYfegh2wiIEaBt6C8UFgdzBhFxTjc130_provenance.
- NP680444.RAx3uUdxrtpiivpJjYfegh2wiIEaBt6C8UFgdzBhFxTjc130_assertion evidence source_evidence_literature NP680444.RAx3uUdxrtpiivpJjYfegh2wiIEaBt6C8UFgdzBhFxTjc130_provenance.
- NP680444.RAx3uUdxrtpiivpJjYfegh2wiIEaBt6C8UFgdzBhFxTjc130_assertion SIO_000772 19228733 NP680444.RAx3uUdxrtpiivpJjYfegh2wiIEaBt6C8UFgdzBhFxTjc130_provenance.
- NP680444.RAx3uUdxrtpiivpJjYfegh2wiIEaBt6C8UFgdzBhFxTjc130_assertion wasDerivedFrom befree-20140225 NP680444.RAx3uUdxrtpiivpJjYfegh2wiIEaBt6C8UFgdzBhFxTjc130_provenance.
- NP680444.RAx3uUdxrtpiivpJjYfegh2wiIEaBt6C8UFgdzBhFxTjc130_assertion wasGeneratedBy ECO_0000203 NP680444.RAx3uUdxrtpiivpJjYfegh2wiIEaBt6C8UFgdzBhFxTjc130_provenance.
- befree-20140225 importedOn "2014-02-25" NP680444.RAx3uUdxrtpiivpJjYfegh2wiIEaBt6C8UFgdzBhFxTjc130_provenance.